>
QuidelQuidel
美國(guó)Quidel公司是一個(gè)上市公司,本著提高人類健康和幸福的目標(biāo),在全球各地開拓、銷售快速檢測(cè)診斷試劑的企業(yè),致力于研發(fā)產(chǎn)品,領(lǐng)域涉及妊娠、傳染病、腫瘤、自身免疫性疾病和骨質(zhì)疏松癥。
Quidel Corporation (Nasdaq: QDEL) is a California-based leading diagnostic healthcare manufacturer serving to enhance the health and well-being of people around the globe through the development of diagnostic solutions that can lead to improved patient outcomes and provide economic benefits to the healthcare system.
Quidel commenced operations in 1979 and launched its first products in 1984. Since that time, Quidel has expanded its product base through internal development and acquisition with a focus on increasing its research and development efforts to accelerate the rate of new product introductions. Our core competencies and capabilities include immunoassay development, automated manufacturing, monoclonal antibody characterization and development, and molecular assay development. Our current products fall generally into these categories: (1) lateral flow, where we are market leaders in infectious disease and reproductive health; (2) direct fluorescent antibodies (DFA), with expertise in infectious disease and virology; (3) micro-titer production, with a focus on bone and complement pathway markets; (4) fluorescent immunoassay products (Sofia); and (5) molecular diagnostic products including the world’s first FDA-cleared handheld molecular device, AmpliVue. Additional molecular and Sofia tests are currently in development or in clinical trials as part of a robust product pipeline.
Whether at our headquarters in San Diego, California, at our research and manufacturing operations in Ohio, Massachusetts, or in Germany, or through our Commercial organization around the world, Quidel is delivering a continuum of diagnostic solutions from advanced lateral-flow and direct fluorescent antibody to molecular diagnostic tests that further improve the quality of healthcare.
產(chǎn)品列表:
Quidel |
MicroVue CIC-C1q EIA |
A001 |
1 kit |
Quidel |
MicroVue CIC Raji Cell Replacement EIA |
A002 |
1 ki |
Quidel |
MicroVue CIC-C1q Controls (Low and High Control) |
A013 |
1 ea. |
Quidel |
MicroVue CH50 Eq EIA |
A018 |
1 kit |
Quidel |
MicroVue Bb Plus Fragment EIA |
A027 |
1 kit |
Quidel |
MicroVue C1 Inhibitor Plus EIA |
A037 |
1 kit |
Quidel |
MicroVue iC3b Fragment EIA – For Research Use Only |
A006 |
1 kit |
Quidel |
MicroVue SC5b-9 Plus EIA – For Research Use Only |
A020 |
1 kit |
Quidel |
MicroVue C5a EIA – For Research Use Only |
A021 |
1 kit |
Quidel |
MicroVue C3a Plus EIA – For Research Use Only |
A031 |
1 kit |
Quidel |
MicroVue Ba Fragment EIA – For Research Use Only |
A033 |
1 kit |
Quidel |
MicroVue C4a EIA – For Research Use Only |
A035 |
1 kit |
Quidel |
MicroVue Animal Pan-Specific C3 Reagent Kit |
20261 |
1 kit |
Quidel |
Prekallikrein Activator (PKA) Assay Kit |
PW30100 |
1 kit |
Quidel |
Prekallikrein Activator (PKA) EP Assay Kit |
PW301EP |
1 kit |
Quidel |
Prekallikrein Activator (PKA) Ig Assay Kit |
PW30200 |
1 kit |
Quidel |
Prekallikrein Activator (PKA) Ig EP Assay Kit |
PW302EP |
1 kit |
Quidel |
Just Positive PKA Control |
PW51005 |
5x0.5 mL |
Quidel |
High Positive PKA Control |
PW52005 |
5x0.5 mL |
Quidel |
Anti-human C9 |
A223 |
100 μL |
Quidel |
Anti-human Factor B (Ba) |
A225 |
100 μL |
Quidel |
Anti-human Factor B (Bb) |
A227 |
100 μL |
Quidel |
Anti-human Factor H #1 |
A229 |
100 μL |
Quidel |
Anti-human Factor I #2 |
A231 |
100 μL |
Quidel |
Anti-human Factor P #1 |
A233 |
100 μL |
Quidel |
Anti-human Factor P #2 |
A235 |
100 μL |
Quidel |
Anti-human S Protein (vitronectin) |
A237 |
100 μL |
Quidel |
Anti-human SC5b-9 (TCC, neoantigen) |
A239 |
100 μL |
Quidel |
Anti-human Clusterin (SP40, 40 and Apo J) |
A241 |
100 μL |
Quidel |
Anti-human Factor I #1 |
A247 |
100 μL |
Quidel |
Anti-human C8 |
A249 |
100 μL |
Quidel |
Anti-human C3d (neoantigen) |
A250 |
100 μL |
Quidel |
Anti-human C4d (neoantigen) |
A251 |
100 μL |
Quidel |
Anti-human Bb (neoantigen) |
A252 |
100 μL |
Quidel |
Anti-human C4 (C4d) |
A253 |
0.5 mL |
Quidel |
Anti-human Factor H #2 |
A254 |
100 μL |
Quidel |
Anti-human Factor H #3 |
A255 |
100 μL |